Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus. (Record no. 20151791)

MARC details
000 -LEADER
fixed length control field 01511 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516001752.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201104s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1365-2230
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1365-2230.2010.03918.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Sebaratnam, D F
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20110429
245 00 - TITLE STATEMENT
Title Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical and experimental dermatology
Date of publication, distribution, etc. Jan 2011
300 ## - PHYSICAL DESCRIPTION
Extent 91-3 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adjuvants, Immunologic
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Topical
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aminoquinolines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Basal Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Imiquimod
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pemphigus
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Toll-Like Receptor 7
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Martin, L K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rubin, A I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tran, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pas, H H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marr, P J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Edmonds, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Murrell, D F
773 0# - HOST ITEM ENTRY
Title Clinical and experimental dermatology
Related parts vol. 36
-- no. 1
-- p. 91-3
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1365-2230.2010.03918.x">https://doi.org/10.1111/j.1365-2230.2010.03918.x</a>
Public note Available from publisher's website

No items available.